Synthesis, Identification and Antimicrobial Activity of 2-Phenyl-3-(Ethyl Acetate)-Quinazolin-4(3h)-One Nucleus Linked with Pyrazole, Pyrazolinone and Pyrimidine Ring
DOI:
https://doi.org/10.61841/d871zy92Keywords:
Quinazolin-4(3H)-one, Pyrazole, Pyrazolinone, Pyrimidine, Anti-microbialAbstract
--A new series of pyrazole, pyrazolinone and pyrimidine derivatives were synthesized from quinazolin-4(3H)-one nucleus and then their actions as antimicrobial agents estimated in present work. Quinazolinone skeleton as starting compound was designed in three steps. The first step including formation of 2-benzamidobenzoic acid [1] by reaction of anthranilic acid with benzoyl chloride. The second step produced 2-phenyl-4H-benzo[3,1]oxazin-4-one [2] from cyclized of compound [1] by acetic anhydride. The third step involved gave 2-phenyl-3-(ethyl acetate)-quinazolin-4(3H)-one [3] by treatment of compound [2] with ethyl glycinate. Compound [3] was reacted with paraphenylenediamine to give 2-phenyl-3-(acetamido-4-aminophenyl)-quinazolin-4(3H)-one [4]. The diazotization of compound [4] with sodium nitrate and concentration HCl at 0-5 oC form diazonium salt that coupled with active methylene compounds such as acetyl acetone and ethyl aceto acetate to afforded corresponding compounds [5] and [6]. Hydrazono acetyl acetone
[5] and hydrazono ethyl aceto acetate [6] treatment with hydrazine and substituted hydrazine to yielded series of pyrazole derivatives [7-11] and pyrazolinone derivatives [12-16] respectively. pyrimidine derivatives [17-18] prepared via cyclization of hydrazono acetyl acetone [5] with urea and thiourea. The newly synthesized compounds elucidate their structure by different spectral techniques involved FTIR, 1H-NMR and 13C-NMR. Some of its physical properties were measured. Furthermore we have evaluated the activity of some prepared compounds against different types of bacteria and fungi strain. The result showed significant effects for these compounds on microorganisms.
Downloads
References
1. Wang, M., Rakesh, K. P., Leng, J., Fang, W. Y., Ravindar, L., Gowda, D. C., & Qin, H. L. (2018). Bioorganic chemistry, 76, 113-129.
2. Martins, P., Jesus, J., Santos, S., Raposo, L. R., Roma-Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2015). Molecules, 20(9), 16852-16891.
3. Zhang, J., Liu, J., Ma, Y., Ren, D., Cheng, P., Zhao, J., & Yao, Y. (2016). Bioorganic & medicinal chemistry letters, 26(9), 2273-2277.
4. Kshirsagar, U. A. (2015). Organic & biomolecular chemistry, 13(36), 9336-9352.
5. Hemalatha, K., & Madhumitha, G. (2016). Journal of Luminescence, 178, 163-171.
6. Patel, T. S., Bhatt, J. D., Vanparia, S. F., Patel, U. H., Dixit, R. B., Chudasama, C. J., & Dixit, B. C. (2017). Bioorganic & medicinal chemistry, 25(24), 6635-6646.
7. Alanazi, A. M., Abdel-Aziz, A. A. M., Shawer, T. Z., Ayyad, R. R., Al-Obaid, A. M., Al-Agamy, M. H., & El-Azab, A. S. (2016). Journal of enzyme inhibition and medicinal chemistry, 31(5), 721-735.
8. Abbas, S. Y., El-Bayouki, K. A., Basyouni, W. M., & Mostafa, E. A. (2018). Medicinal Chemistry Research, 27(2), 571-582.
9. Elshahawi, M. M., EL-Ziaty, A. K., Morsy, J. M., & Aly, A. F. (2016). Journal of Heterocyclic Chemistry, 53(5), 1443-1448.
10. Gobinath, M., Subramanian, N., Alagarsamy, V., Nivedhitha, S., & Solomon, V. R. (2015). Tropical Journal of Pharmaceutical Research , 14(2), 271-277.
11. Amir, M., Ali, I., & Hassan, M. Z. (2013). Archives of pharmacal research, 36(1), 61-68.
12. Li, M., & Zhao, B. X. (2014). European journal of medicinal chemistry, 85, 311-340.
13. Kong, Y., Tang, M., & Wang, Y. (2013). Organic letters, 16(2), 576-579.
14. Zhang, X., Kang, J., Niu, P., Wu, J., Yu, W., & Chang, J. (2014). The Journal of organic chemistry, 79(21), 10170-10178.
15. Khan, M. F., Alam, M. M., Verma, G., Akhtar, W., Akhter, M., & Shaquiquzzaman, M. (2016). European journal of medicinal chemistry, 120, 170-201.
16. Sayed, M., & Ahmed, N. (2017). Journal of Advanced PharmacyResearch, 1(2), 75-88.
17. Bhat, A. R., Dongre, R. S., Naikoo, G. A., Hassan, I. U., & Ara, T. (2017). Journal of Taibah University for Science,11(6),1047-1069.
18. Cano, P. A., Islas-Jácome, A., Rangel-Serrano, Á., Anaya-Velázquez, F., Padilla-Vaca, F., Trujillo-Esquivel, E., & Gámez-Montaño, R., (2015). Molecules, 20(7),12436-12449
19. Hayder, M. M., (2017). M.Sc. Thesis, Chem. Dept , Colle. of Sci, Bagh. Univ, Iraq.
20. El-Sawy, A. A., Mohamed, S. K., Eissa, A. E. M. M., Tantawy, A. H., & Issac, Y. A., (2012). Journal of Chemical and Pharmaceutical Research, 4(5), 2755-2762.
21. Redhab, A., & Suaad, M., (2014). Iraqi Journal of Science, 55(4), 1694-1707.
22. Kandhavelu, M., Paturu, L., Mizar, A., Mahmudov, K. T., Kopylovich, M. N., Karp, M., & Ribeiro, A. S., (2012). Pharmaceutical Chemistry Journal, 46(3), 157-164.
23. Subramanyam, S., Raja, S., Jayaveera K., & Sunil, K., (2012). International Journal of Innovative Pharmaceutical Research, 3(1), 187-193.
24. Nofal, Z. M., Fahmy, H. H., Zarea, E. S., & El-Eraky, W. A. F. A. A. (2011). Acta Pol Pharm, 68(4), 507-517.
25. Shriner, R.L., Fuson, R.C., Curtin, D.Y., Morrill, T.C. (1980). 6th ed., John Wiley, New York, USA.
26. Silverstein, R. M., Webster, F. X., Kiemle, D. J., & Bryce, D. L. (2015). 8th ed., John wiley & sons, Hoboken, USA.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
